Free provider profile

LYNSAY BRAUTNICK, M.D.

NPI 1548317340
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like LYNSAY BRAUTNICK?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What LYNSAY BRAUTNICK prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Creon
  • Jakafi
  • Cabometyx
  • Stivarga
  • Pomalyst

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

479-587-1700

Fax

479-587-1366

Practice address

3232 N NORTH HILLS BLVD, FAYETTEVILLE, AR, 72703

Registry updated
2026-07-06
NPI issued
2007-01-04
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

3232 N NORTH HILLS BLVD, FAYETTEVILLE, AR, 72703

479-587-1700

3 practice locations listed

Enumerated 2007-01-04

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 3 practice locations listed — multi-site footprint.
  • — Record updated within the last year.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,838

Medicare patients

343

Part D drug cost

$3,578,132

Brand-name share

23.8%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Jakafi (Ruxolitinib Phosphate)51$845,531
Cabometyx (Cabozantinib S-Malate)21$419,728
Fruzaqla (Fruquintinib)13$292,123
Stivarga (Regorafenib)15$213,819
Pomalyst (Pomalidomide)14$182,266
Doptelet (Avatrombopag Maleate)11$136,519
Xermelo (Telotristat Etiprate)13$125,177
Creon (Lipase/Protease/Amylase)62$92,137

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across AR — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.